Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins

Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins

Ovarian cancer metastization is accompanied by the development of malignant ascites, which are associated with poor prognosis. The acellular fraction of this ascitic fluid contains tumor-promoting soluble factors, bioactive lipids, cytokines, and extracellular vesicles, all of which communicate with...

Full description

Bibliographic Details
Main Authors:	Diana Luísa Almeida-Nunes, Ricardo Silvestre, Ricardo Jorge Dinis-Oliveira, Sara Ricardo
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	International Journal of Molecular Sciences
Subjects:	ovarian cancer metabolomics T-cell exhaustion drug repurposing clinical trials
Online Access:	https://www.mdpi.com/1422-0067/25/1/323

Similar Items

Combining paclitaxel with repurposing drugs improve ovarian cancer management
by: Mariana Nunes, et al.
Published: (2022-04-01)

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer
by: Mariana Nunes, et al.
Published: (2020-10-01)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
by: Diana Luísa Almeida-Nunes, et al.
Published: (2022-09-01)

Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by: Jiřina Bartůňková
Published: (2024-03-01)

The influence of tumor microenvironment immune in ovarian cancer ascites
by: Diana Nunes, et al.
Published: (2022-04-01)

The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial
by: Dominique E. Martin, et al.
Published: (2023-05-01)

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
by: Yusuke Kobayashi, et al.
Published: (2022-01-01)

Ovarian cancer: Current status and strategies for improving therapeutic outcomes
by: Ashwin Chandra, et al.
Published: (2019-11-01)

Emerging Role of Metabolomics in Ovarian Cancer Diagnosis
by: Asia Saorin, et al.
Published: (2020-10-01)

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line
by: Mariana Nunes, et al.
Published: (2022-12-01)

Statins as Repurposed Drugs in Gynecological Cancer: A Review
by: Kai-Hung Wang, et al.
Published: (2022-11-01)

Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
by: Anna Roberto, et al.
Published: (2018-04-01)

Use of repurposed drugs in COVID-19 pandemic: Old drugs without new tricks?
by: Suraj Kapoor
Published: (2023-01-01)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
by: Shraddha M. Dalwadi, et al.
Published: (2023-05-01)

Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy
by: Marco Luciani, et al.
Published: (2017-08-01)

A Database of Drug Repurposing Clinical Trials in Oncology
by: Pan Pantziarka, et al.
Published: (2021-11-01)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
by: Linjuan Huang, et al.
Published: (2023-07-01)

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
by: Linah F. Al-Alem, et al.
Published: (2019-10-01)

Immunotherapy in Gynaecological Oncology: The Italian Landscape
by: Luca Pace, et al.
Published: (2023-05-01)

Drug resistance in ovarian cancer: from mechanism to clinical trial
by: Ling Wang, et al.
Published: (2024-03-01)

Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial
by: Joaquín Llácer, et al.
Published: (2020-02-01)

Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
by: Mary P. Udumula, et al.
Published: (2022-03-01)

Pharmacokinetics and Metabolomic Profiling of Metformin and <i>Andrographis paniculata</i>: A Protocol for a Crossover Randomised Controlled Trial
by: Khim Boon Tee, et al.
Published: (2022-07-01)

Comparison of Therapeutic Effects in terms of Menstrual Irregularities between Statins and Metformin in Unmarried Patients with Polycystic Ovarian Syndrome
by: Sobia Nawaz, et al.
Published: (2023-08-01)

Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01)

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice
by: Campbell R, et al.
Published: (2023-05-01)

Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer
by: Prachi Gupta, et al.
Published: (2022-05-01)

Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals
by: Ching-Huan Wang, et al.
Published: (2022-02-01)

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
by: Frauke Assmus, et al.
Published: (2022-08-01)

Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
by: Mohamed El-Tanani, et al.
Published: (2023-05-01)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
by: Ashour NA, et al.
Published: (2022-03-01)

Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
by: J. Silvio Gutkind, et al.
Published: (2021-09-01)

Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far
by: Md. Jamal Hossain, et al.
Published: (2021-09-01)

Peripheral Blood Serum NMR Metabolomics Is a Powerful Tool to Discriminate Benign and Malignant Ovarian Tumors
by: Sofia C. Nunes, et al.
Published: (2023-09-01)

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
by: Clare eScott, et al.
Published: (2013-12-01)

Clinical analysis for a case of ovarian cancer complicated with ovarian abscess
by: Li Ping, Shi Shanshan
Published: (2022-05-01)

Phenotypic evaluation of the ovarian tumor cells presents in malignant ascites
by: Sílvia Ferreira, et al.
Published: (2022-04-01)

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
by: Yani Berckmans, et al.
Published: (2023-06-01)

Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer
by: Jiawen Zhang, et al.
Published: (2020-08-01)

Ovarian torsion as an emergency clinical entity
by: Evrim Gul, et al.
Published: (2020-03-01)